Abstract
Group B streptococcus (GBS) early-onset sepsis is a leading cause of neonatal morbidity and mortality. Two-thirds of infants with GBS sepsis are born to mothers with a negative third-trimester GBS culture—the current screening test. Given the transient nature of GBS colonization we evaluated the test characteristics of a rapid intrapartum GBS test and the current screening test along with the incidence of GBS conversion from the third trimester to intrapartum.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have